OraSure License/Marketing Pact With Abbott To Aid OraQuick HIV Test Launch
This article was originally published in The Gray Sheet
Executive Summary
OraSure Technologies' license of non-exclusive rights to certain test strip technology patents from Abbott appears to clear the way for a U.S. launch of OraSure's OraQuick rapid HIV-1 test, pending FDA approval